Early Selective Ibuprofen for Patent Ductus Arteriosus Fails to Improve Outcomes in Extremely Preterm Infants: Insights from the Baby-OSCAR Trial

Highlights

The Baby-OSCAR trial investigated whether early selective treatment of a large patent ductus arteriosus (PDA) with ibuprofen improves clinical outcomes in extremely preterm infants.

Primary findings indicated no statistically significant difference in the composite outcome of death or moderate-to-severe bronchopulmonary dysplasia (BPD) at 36 weeks’ post-menstrual age between the ibuprofen and placebo groups.

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply